Information Center

Cooperate with Yangtze River Pharmaceutical Group

Release time:

2023-04-19 23:51

User reviews and feedback:

Nanjing Baidier Biopharmaceutical Co., Ltd. transferred the raw material and capsule development technology of Lenalidomide to our company. This technology is mature and stable, with reliable quality. After our company acquired the raw material development technology and capsule development technology, we completed further industrial scale-up production based on this foundation, successfully completed multiple batches of validation production, and passed the bioequivalence study. In July 2020, we obtained the production license. This technology transfer has realized the key process from research and development to production, playing a very important role in the quality and market launch of our products. On September 18, the Internet hospital sold the first box of Lenalidomide capsules (Youjia) produced by Yangtze River Pharmaceutical Group Co., Ltd., marking the successful transition from implementation to market sales.

Previous Page

Next Page

Previous Page

Next Page


Beijing Address: A203, Zhongguancun Biomedical Park, No.5, Development Road, Haidian District, Beijing
Zhejiang Address: Floor 8, Building 7, Dongsheng Huigu, 1299 Kehai Avenue, Keqiao District, Shaoxing City, Zhejiang Province
Contact Phone:010-82176552
E-mail:hr@kanovabiopharma.com

©2024 Zhejiang Kanova biopharmaceutical Co., LTD

Power by:300.cn  Beijing

Business License